So, in this case, the jump in points on the CSS score represents clinical improvement in HFpEF
The first cardiovascular safety trial of a GLP-1R agonist, demonstrating that lixisenatide does not augment MACE in patients with T2DM who had a recent acute coronary event
At the end of the day, you should make healthy lifestyle choices that make the most sense for your own body
Do not use the medication if you notice dramatic color changes, cloudiness, particles, or precipitation
BniSchnetzler M, Schmid C, Meier PJ, Froesch ER
Anti-and pro-oxidant potential of lettuce ( Lactuca sativa L.) biofortified with iodine by KIO3, 5-iodo-and 3, 5-diiodosalicylic acid in human gastrointestinal cancer cell lines